{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-042570","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2025-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.178166+00:00","generated_at":"2026-05-23T02:24:09.214587+00:00","sec_items":["1.01","1.02","2.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"confidence":"high","headline":"Avenue Therapeutics terminates AJ201 license; gets $2M cash, up to $24M milestones, 1.75% royalty","bullets":["License terminated; all AJ201 rights and assets transferred back to AnnJi; mutual releases and dismissal of disputes.","Avenue to receive $2M total within 90 days: $1M due in 30 days, $1M due in 90 days.","Potential future payments: up to $5M development milestones, up to $17M commercial milestones, 1.75% royalty on net sales.","Avenue repurchases 14,777 shares from AnnJi for $1.00 aggregate and pays $0.2M for AnnJi legal expenses.","48-month non-compete for competing products in US, Canada, EU, UK, and Israel after termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-042570","json":"https://secwatch.observer/filing/0001104659-25-042570.json","markdown":"https://secwatch.observer/filing/0001104659-25-042570.md","text":"https://secwatch.observer/filing/0001104659-25-042570.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000110465925042570/0001104659-25-042570-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000110465925042570/tm2513615d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T02:24:09.214587+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}